In 2010 June, a much awaited regulation on e-prescribing of controlled substances (EPCS) was released by the Drug Enforcement Administration (DEA). This was to take away a massive hurdle in the use of electronic prescribing and health care technology. Until now, a handful of HIT vendors and pharmacies have been able to offer the ability to e-prescribe controlled substances. This is primarily because of the problems in meeting the stringent DEA and certification requirements. There are also massive costs involved and the ability to create effective two-factor authentication lies with very few. In a bid to becoming a catalyst to the nationwide implementation and adoption of EPCS, the Institute for Health Technology Transformation (iHT2) will be hosting the EPCS Leadership Symposium on April 17-18, 2012 in Washington DC. This conference is the first-of-its-kind and will have many of the leading HIT vendors including the presenting sponsor DrFirst. Security experts such as Experian and Symantec will be sharing their experiences, successes, and hurdles with EPCS.
This EPCS Leadership Symposium will provide a chance for the decision makers in the health care sector to get together, learn, and share the most recent of knowledge and advancements in the area of medication management, patient data security and also other issues concerning the EPCS. The agenda will provide a glimpse into the most recent clinical information technologies as well as strategies, panel discussions that have taken place with industry experts and focus groups. It will also have presentations on the latest e-prescribing issues besides others agendas.
In a release, G. Cameron Deemer, President of DrFirst said, “We are pleased to be the presenting sponsor for this first-of-its kind symposium focusing on the electronic transmission of controlled substance prescriptions. As a company that has a laser-focus on positively benefiting providers in all our endeavors, this is a great opportunity to make an impact on the entire health IT industry on their behalf. By working together with iHT2, and some of the most well-known and respected professionals in the field, it is our goal to shed light on how to accelerate the adoption of EPCS by providing the insight and experience we acquired during the original EPCS pilot study in Massachusetts.”
Carolyn John is a Contributor to HealthTechZone. To read more of her articles, please columnist page.Edited by
Rich Steeves